Jurimex advised the leading medicine manufacturer on Ukrainian antimonopoly legislation issues in the process of global business acquisition.

Our lawyers had provided the client with the detailed legal conclusion on antitrust legislation of Ukraine that over time has been approved by the preliminary conclusion of the Antimonopoly Committee.

As a result the statement on concentration clearance was duly filed and considered by the Committee, on the basis of which the resolution was passed for the benefits of the client.